Top level navigation

Breadcrumb to current page

Main content

In the news

HRB invests €10 million in four new clinical trial networks

19 May 2015

Stroke patients, mothers and babies, primary care and intensive care patients will all benefit from the four new clinical trial networks, which will improve people’s health and patient care by addressing important research questions.

Dr Graham Love, the Chief Executive at the Health Research Board (HRB) says,
‘Clinical trials matter. These new HRB networks will show whether specific interventions work, or indeed don’t work, in the areas of stroke, intensive care, perinatal care and primary care.'

The four Clinical Trials Networks are:

  • HRB Irish Stroke Clinical Trials Network led by Professor Peter J Kelly, Mater University Hospital and University College Dublin (UCD).
  • HRB Irish Critical-Care Clinical Trials Group led by Professor Alistair Nichol, St Vincent’s University Hospital and UCD.
  • HRB Ireland Perinatal Clinical Trials Network co-led by Professor Fergal Malone, Rotunda Hospital and Royal College of Surgeons in Ireland and Professor Louise Kenny, Cork University Maternity Hospital and INFANT, University College Cork (UCC).
  • HRB Irish Primary Care Trials Network led by Professor Andrew Murphy, Foundation Professor of General Practice NUI Galway and General Practitioner Turloughmore, County Galway.

He adds,

'The clinical trial network approach is effective. We know this because we have our own tried and tested network in Cancer called ICORG*, which is co-funded by the Irish Cancer Society. Since the HRB started funding ICORG in 2001, it has attracted 270 international trials to Ireland, provided more than 13,000 Irish cancer patients with access to new research treatments and drawn in €6.95 million in funding from industry in the last three years alone’.

More details are available from the press release at the link below this article.

Search the HRB website

Other information and links